A PHASE 2, RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO COMPARE THE EFFICACY AND SAFETY OF A CHEMOKINE CCR2/5 RECEPTOR ANTAGONIST (PF-04634817) WITH THAT OF RANIBIZUMAB IN ADULT SUBJECTS WITH DIABETIC MACULAR EDEMA
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/08/2014 - 01/04/2015
Description
Keywords: Klinische Studie; Pfizer DME
Funding identifier: B1261009
Funder / funding scheme:
- Parexel International GmbH
Project management at the University of Münster
| Eter, Nicole | Clinic for Ophthalmology |
Applicants from the University of Münster
| Eter, Nicole | Clinic for Ophthalmology |